Using real world decisions to develop a modified central IRB model
使用现实世界的决策来开发修改后的中央 IRB 模型
基本信息
- 批准号:8840421
- 负责人:
- 金额:$ 37.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-15 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgreementCognitiveCommitDataData AnalysesEffectivenessEnsureEthicsEvaluationFoundationsFundingFutureHumanInformaticsInstitutionInstitutional Review BoardsInvestigationLeadLeadershipLearningLegalLettersMeasuresMedicalMethodsMetricMissionModelingModificationMovementMulticenter StudiesNatural experimentOffice for Human Research ProtectionsOnline SystemsOutcomeOutcome MeasurePhysician ExecutivesPoliciesPredispositionProceduresProcessProcess MeasureProtocols documentationRelianceResearchResearch InfrastructureResearch PersonnelRiceSecureSolutionsSystemTimeTrustWorkbasecontextual factorsdesignempoweredevidence baseexperiencehuman subjecthuman subject protectionimprovedoperationprogramspublic health relevancesatisfactionstemstudy characteristics
项目摘要
DESCRIPTION (provided by applicant): The IRB review of multicenter studies has known inefficiencies, produces variable outcomes, and may not sufficiently protect human subjects. One proposed solution has been the utilization of central IRB (CIRB) review; however, existing CIRB models have significant scalability issues and lack empirical evidence of effectiveness due to low utilization. Understanding how and why IRBs decide what IRB review model is best within the study context is essential to designing a model that accommodates these decisions. Given that the suitability of a multicenter study for CIRB or an alternative IRB review model may vary widely, a single IRB review model may not be sufficient for a study with multiple, diverse institutions. The existing infrastructure supporting IRBshare can be leveraged to accommodate multiple IRB review models - including shared review, central review, and local review - and provide a real world platform for subsequently capturing data in the course of operations. It is hypothesized that empowering institutions with the opportunity to choose the model that contextually works best-based on the institutional and study characteristics-will encourage greater utilization that can in turn improve the ethical quality and efficaciousness of multisite IB review. The choices, utilization, process, and rationale for selecting an IRB review model for a given study when multiple review options are available ("IRBchoice") will be analyzed using qualitative and quantitative measures and analyses. SPECIFIC AIMS: 1) To use an adapted informatics system and coordinated program to track real world decisions and capture the rationale used when selecting an IRB reliance model, including the facilitators and barriers to utilizing alternative IRB review models at the institutional, legal, HRPP/IRB, investigator, and study levels; 2) To compare the alternative review models on key process and outcome measures: a) ethical quality, b) efficiency of the review process, and c) satisfaction with the review process by multiple stakeholders (IRB, sponsor/funder, investigator/study team); and 3) To develop and share policies and procedures to mitigate ethical or logistical issues and maximize efficiency related to the dynamic use of alternative review models including the CIRB model.
描述(由申请人提供):IRB 对多中心研究的审查已知效率低下,产生不同的结果,并且可能无法充分保护人类受试者。一项提议的解决方案是利用中央 IRB (CIRB) 审查;然而,现有的 CIRB 模型存在严重的可扩展性问题,并且由于利用率低而缺乏有效性的经验证据。了解 IRB 如何以及为何决定哪种 IRB 审查模型在研究背景下最好,对于设计适应这些决策的模型至关重要。鉴于 CIRB 或替代 IRB 审查模型的多中心研究的适用性可能差异很大,单一 IRB 审查模型可能不足以用于多个、不同机构的研究。可以利用支持 IRBshare 的现有基础设施来适应多种 IRB 审核模式(包括共享审核、集中审核和本地审核),并为随后在运营过程中捕获数据提供一个真实的平台。据推测,让机构有机会根据机构和研究特点选择最适合具体情况的模型,将鼓励更多的利用,从而提高多地点 IB 审查的道德质量和有效性。当有多个审查选项可用时(“IRB选择”),将使用定性和定量测量和分析来分析为给定研究选择IRB审查模型的选择、利用、过程和理由。具体目标: 1) 使用适应的信息学系统和协调计划来跟踪现实世界的决策并捕获选择 IRB 依赖模型时使用的基本原理,包括在机构、法律、HRPP/ IRB、研究者和研究级别; 2) 比较关键流程和结果衡量的替代审核模型:a) 道德质量,b) 审核流程的效率,以及 c) 多个利益相关者(IRB、申办者/资助者、研究者/研究团队)对审核流程的满意度); 3) 制定和共享政策和程序,以减轻道德或后勤问题,并最大限度地提高与动态使用替代审查模型(包括 CIRB 模型)相关的效率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD W RICE其他文献
TODD W RICE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD W RICE', 18)}}的其他基金
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network
急性肺损伤的预防和早期治疗临床试验网络
- 批准号:
9063082 - 财政年份:2014
- 资助金额:
$ 37.05万 - 项目类别:
Using real world decisions to develop a modified central IRB model
使用现实世界的决策来开发修改后的中央 IRB 模型
- 批准号:
8927057 - 财政年份:2014
- 资助金额:
$ 37.05万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8610942 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8240853 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8424973 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7913067 - 财政年份:2006
- 资助金额:
$ 37.05万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7475149 - 财政年份:2006
- 资助金额:
$ 37.05万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7294344 - 财政年份:2006
- 资助金额:
$ 37.05万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7133071 - 财政年份:2006
- 资助金额:
$ 37.05万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7666915 - 财政年份:2006
- 资助金额:
$ 37.05万 - 项目类别:
相似国自然基金
区域吞吐能效导向的RF能量收集认知无线传感器网络分簇节能设计研究
- 批准号:61901102
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于水声认知技术的数据传输模型与协议研究
- 批准号:61702487
- 批准年份:2017
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
面向风电监测的认知无线传感器网络的APTEEN路由协议及其优化研究
- 批准号:61761034
- 批准年份:2017
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
认知无线传感器网络的关键组网协议设计与优化
- 批准号:61673371
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
基于协作和认知的网络化传感系统中大数据传输技术研究
- 批准号:61671165
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Label-free, live-cell classification of neural stem cell activation state and dynamics
神经干细胞激活状态和动力学的无标记活细胞分类
- 批准号:
10863309 - 财政年份:2023
- 资助金额:
$ 37.05万 - 项目类别:
Re-examining links between screen time, health behaviors, and executive functioning: Validating an objective measure of screen exposure in a sample of young children
重新审视屏幕时间、健康行为和执行功能之间的联系:验证幼儿样本中屏幕暴露时间的客观测量
- 批准号:
10725847 - 财政年份:2023
- 资助金额:
$ 37.05万 - 项目类别:
IND-enabling studies for cell therapy in Parkinson's disease
帕金森病细胞疗法的 IND 研究
- 批准号:
10760861 - 财政年份:2023
- 资助金额:
$ 37.05万 - 项目类别:
Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine.
具有处方阿片类药物依赖性的提供者和老年疼痛患者:一项定性研究,旨在了解阿片类药物逐渐减少、戒断和过渡到丁丙诺啡的障碍。
- 批准号:
10671358 - 财政年份:2023
- 资助金额:
$ 37.05万 - 项目类别:
mGlide-Care: A mHealth Partnership with Care Givers to Improve HTN Management in Patients with Cognitive Impairment
mGlide-Care:与护理人员建立 mHealth 合作伙伴关系,以改善认知障碍患者的 HTN 管理
- 批准号:
10661238 - 财政年份:2023
- 资助金额:
$ 37.05万 - 项目类别: